Totoxic investigations of Pereskia grandifolia Haw. (Cactaceae) leaves. J Biol SciTotoxic investigations of Pereskia grandifolia

Totoxic investigations of Pereskia grandifolia Haw. (Cactaceae) leaves. J Biol Sci
Totoxic investigations of Pereskia grandifolia Haw. (Cactaceae) leaves. J Biol Sci 2009, 9:48893. 52. Takeara R, Jimenez Pc, Wilke DV, Odorico de Moraes M, Pessoa C, Peporine Lopes N, Lopes JLC, Monteiro da Cruz Lotufo T, Costa Lotufo LV: Antileukemic effects of Didemnum psammatodes (Tunicata: Ascidiacea) constituents. Comp Biochem Physiol A Mol Integr Physiol 2008, 151:363��369. 53. Miret S, De Groene EM, Klaffke W: Comparison of in vitro assays of cellular toxicity within the human hepatic cell line HepG2. J Biomol Screen 2006, 11:18493. 54. Syed Abd Rahman SN, Abdul Wahab N, Abd Malek SN: In vitro morphological assessment of apoptosis induced by antiproliferative constituents in the rhizomes of XIAP manufacturer Curcuma zedoria. Evid Based Complement Alternat Med 2013, 2013:14.doi:10.1186/1472-6882-13-243 Cite this short article as: Phang et al.: Antioxidant potential, cytotoxic activity and total phenolic content material of Alpinia pahangensis rhizomes. BMC Complementary and Alternative Medicine 2013 13:243.Submit your next manuscript to BioMed Central and take complete benefit of:Easy on line submission Thorough peer review No space constraints or colour figure charges Instant publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Investigation that is freely offered for redistributionSubmit your manuscript at biomedcentral.com/submit
Drugs R D (2014) 14:17784 DOI ten.1007/s40268-014-0055-ORIGINAL Investigation ARTICLESwitching a-Glucosidase Inhibitors to Miglitol Lowered Glucose Fluctuations and Circulating Cardiovascular Disease Threat Aspects in Variety 2 Diabetic Japanese PatientsNatsuyo Hariya Kazuki Mochizuki Seiya Inoue Miyoko Saito Masahiro Fuchigami Toshinao Goda Takeshi OsonoiPublished on-line: 31 July 2014 The Author(s) 2014. This short article is published with open access at Springerlink.comAbstract Background and Objectives Within this study we examined the effects of switching a-glucosidase inhibitors (a-GI) from acarbose or voglibose to miglitol on glucose fluctuations and circulating concentrations of cardiovascular disease threat things, like soluble adhesion molecules (5-LOX Antagonist web sE-selectin, sICAM-1 and sVCAM-1), a chemokine monocyte chemoattractant protein (MCP)-1, plasminogen activator inhibitor-1, and fatty acid-binding protein 4, in variety 2 diabetic sufferers for three months. Methods We enrolled 47 Japanese individuals with sort 2 diabetes, with HbA1c levels with 7.26 0.five (imply common deviation), and who have been treated using the highest authorized dose of acarbose (100 mg/meal) or voglibose (0.three mg/meal) in combination with insulin or sulfonylurea.N. Hariya Division of Engineering, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Kofu, Japan K. Mochizuki S. Inoue T. Goda Division of Food and Nutritional Sciences, Graduate College of Nutritional and Environmental Sciences, University of Shizuoka, Shizuoka, Japan K. Mochizuki ( ) Laboratory of Food and Nutritional Sciences, Department of Neighborhood Make and Food Sciences, Faculty of Life and Environmental Sciences, University of Yamanashi, 4-4-37 Takeda, Kofu, Yamanashi 400-8510, Japan e-mail: [email protected] M. Saito T. Osonoi Naka Kinen Clinic, Ibaraki, Japan M. Fuchigami Pharmaceutical Analysis Laboratories, Sanwa Kagaku Kenkyusho Co., Ltd, Mie, JapanPatients’ prior a-GIs were switched to a medium dose of miglitol (50 mg/meal), as well as the new therapies have been maintained for 3 months. Thirty-five individuals who completed the 3-month study and provided serum samples.